Published On: July 7th, 2009
As U.S. drug sales start to slow, pharmaceutical companies are turning to the developing world for growth. In Venezuela, Pfizer is pitching its brand-name drugs over local no-name competitors. Avery Johnson reports from Venezuela.

Excerpt from:
Pfizer’s New Market: Venezuela’s Working Poor/a>
Loading...
Leave a comment



Did you know:




